Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Astellas' Isavuconazonium Should Pass Ad Comm Meeting For 2 Indications
Astellas' Isavuconazonium Should Pass Ad Comm Meeting For 2 Indications
Astellas' Isavuconazonium Should Pass Ad Comm Meeting For 2 Indications
Submitted by
admin
on January 21, 2015 - 12:00pm
Source:
Seeking Alpha
News Tags:
Astellas
Isavuconazonium
FDA
advisory panels
aspergillosis
mucormycosis
Headline:
Astellas' Isavuconazonium Should Pass Ad Comm Meeting For 2 Indications
Do Not Allow Advertisers to Use My Personal information
